PharmTech LCGC Sciex Webinar 11.10
|Articles|April 15, 2009

Dionex Names President and CEO

Dionex Corporation (Sunnyvale, California) announced that its next president, chief executive officer (CEO), and member of its board of directors will be Dr. Frank Witney, effecive April 30, 2009.

Dionex Corporation (Sunnyvale, California) announced that its next president, chief executive officer (CEO), and member of its board of directors will be Dr. Frank Witney, effecive April 30, 2009. Dr. Lukas Braunschweiler resigned as president and CEO to accept a new position as CEO of Ruag Holding AG, a Switzerland-based aviation, defense, and technology company. Witney reportedly has 25 years of experience in the life science and analytical instrumentation industry with companies such as Affymetrix, Panomics, PerkinElmer, and Bio-Rad. He was a postdoctoral fellow at the National Institutes of Health and holds a doctorate in molecular and cell biology from Indiana University.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.